Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Opinion in Toxicology
|
October 24, 2017
Concise Review: Current and Emerging Biomarkers of Nephrotoxicity
Elijah J Weber, Jonathan Himmelfarb, Edward J Kelly
Clinical Pharmacology in Drug Development
|
February 12, 2024
Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist
Elijah J Weber, Islam R Younis, Lulu Wang, et al.
Journal of Clinical Pharmacology
|
March 7, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver Disease
Islam R Younis, Elijah J Weber, Cara Nelson, et al.
Journal of Clinical Pharmacology
|
March 23, 2024
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment
Islam R Younis, Cara Nelson, Elijah J Weber, et al.
Clinical Pharmacokinetics
|
September 18, 2024
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase
Elijah J Weber, Islam R Younis, Cara Nelson, et al.
Current Protocols in Toxicology
|
August 5, 2017
Microphysiological Systems to Assess Nonclinical Toxicity
Kirk P Van Ness, Shih-Yu Chang, Elijah J Weber, et al.
Journal of Clinical Pharmacology
|
August 30, 2024
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese Participants
Islam R Younis, Cara Nelson, Elijah J Weber, et al.
Journal of the American Society of Nephrology : JASN
|
October 27, 2018
A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation
Maria B Monteiro, Susanne Ramm, Vidya Chandrasekaran, et al.
Scientific Reports
|
October 7, 2018
Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip
Courtney Sakolish, Elijah J Weber, Edward J Kelly, et al.
JCI Insight
|
December 5, 2017
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity
Shih-Yu Chang, Elijah J Weber, Viktoriya S Sidorenko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Opinion in Toxicology
|
October 24, 2017
Concise Review: Current and Emerging Biomarkers of Nephrotoxicity
Elijah J Weber, Jonathan Himmelfarb, Edward J Kelly
Clinical Pharmacology in Drug Development
|
February 12, 2024
Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist
Elijah J Weber, Islam R Younis, Lulu Wang, et al.
Journal of Clinical Pharmacology
|
March 7, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver Disease
Islam R Younis, Elijah J Weber, Cara Nelson, et al.
Journal of Clinical Pharmacology
|
March 23, 2024
Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment
Islam R Younis, Cara Nelson, Elijah J Weber, et al.
Clinical Pharmacokinetics
|
September 18, 2024
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase
Elijah J Weber, Islam R Younis, Cara Nelson, et al.
Current Protocols in Toxicology
|
August 5, 2017
Microphysiological Systems to Assess Nonclinical Toxicity
Kirk P Van Ness, Shih-Yu Chang, Elijah J Weber, et al.
Journal of Clinical Pharmacology
|
August 30, 2024
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese Participants
Islam R Younis, Cara Nelson, Elijah J Weber, et al.
Journal of the American Society of Nephrology : JASN
|
October 27, 2018
A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation
Maria B Monteiro, Susanne Ramm, Vidya Chandrasekaran, et al.
Scientific Reports
|
October 7, 2018
Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip
Courtney Sakolish, Elijah J Weber, Edward J Kelly, et al.
JCI Insight
|
December 5, 2017
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity
Shih-Yu Chang, Elijah J Weber, Viktoriya S Sidorenko, et al.
Page
of 2